Real-time enrollment status for this diabetic peripheral neuropathic pain clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 3:14 PM UTC
| NCT Number | NCT07231419 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Peripheral Neuropathic Pain |
| Phase | PHASE3 |
| Target Enrollment | 734 participants |
| Active Locations | 75 sites in the US |
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Last Updated on CT.gov | July 20, 2026 (Jul 20, 2026) |
As of August 27, 2026: Clinical trial NCT07231419 is currently recruiting participants. This phase3 study for diabetic peripheral neuropathic pain is actively seeking new participants at 75 locations across the United States. The study is sponsored by Vertex Pharmaceuticals Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07231419 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 75 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07231419 was last updated Jul 20, 2026 (July 20, 2026). HelloStudys verifies this status automatically.